Continuous flow blood pumps: The new gold standard for advanced heart failure?

European Journal of Cardio-thoracic Surgery

Volumn 44, Issue 1, 2013, Pages 4-8

  Westaby, Stephen ^a   Deng, Mario ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Continuous flow pump; Heart failure; Heart transplantation; Mechanical circulatory support

Indexed keywords

ASSISTED CIRCULATION; BLOOD FLOW; BLOOD PUMP; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; COMORBIDITY; EDITORIAL; FORWARD HEART FAILURE; GOLD STANDARD; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUNG VASCULAR RESISTANCE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC DYSFUNCTION;

CONTINUOUS FLOW PUMP; HEART FAILURE; HEART TRANSPLANTATION; MECHANICAL CIRCULATORY SUPPORT;

AGED; AGED, 80 AND OVER; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MIDDLE AGED; PROSTHESIS IMPLANTATION;

EID: 84879573541     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt248     Document Type: Editorial

References (42)

1. Clark AL. Origin of symptoms in chronic heart failure. Heart 2006;92:12-6.
2. Hunt SA. Taking heart-cardiac transplantation. N Engl J Med 2006;355: 231-5.
3. Gott M, Barnes S, Parker C, Payne S, Seamark D, Gariballa S et al. Dying trajectories in heart failure. Palliat Med 2007;21:95-9.
4. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125: e2-220.
5. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplantation report-2010. J Heart Lung Transplant 2010;29:1089-103.
6. Hauptman PJ, Goodlin SJ, Lopatin M, Constanzo MR, Fonarow CG, Yancy CW. Characteristics of patients hospitalised with acute decompensated heart failure who are referred for hospice care. Arch Intern Med 2007;167: 1990-7.
7. Hunt SA, Rider AK, Stinson EB, Griepp RD, Schroeder JS, Harrison DC et al. Does cardiac transplantation prolong life and improve its quality? An updated report. Circulation 1976;54(Suppl):356-60.
8. Kilic A, Weiss ES, George TJ, Arnaoutakis GJ, Yuh DD, Shah AS et al. What predicts long term survival after heart transplantation? An analysis of 9400 ten year survivors. Ann Thorac Surg 2012;93:699-704.
9. Deng MC, Ardehali A, Shemin R, Hickey A, MacLellan R, Fonarow G. Relative roles of heart transplantation and long term mechanical circulatory support in contemporary management of advanced heart failure-a critical appraisal ten years after REMATCH. Eur J Cardiothorac Surg 2011; 40:781-2.
10. Kilic A,Weiss ES, Allen JG, George TJ, Yuh D, Shah AS et al. Should orthotopic heart transplantation using marginal donors be limited to higher volume centres. Ann Thorac Surg 2012;94:695-702.
11. Deng MC, DeMeester JMJ, Smits JM, Heinecke J, Scheld HH, on behalf of the COCPIT study group. The effect of receiving a heart transplant: analysis of a national cohort entered onto waiting list, stratified by heart failure severity. Br Med J 2000;321:540-5.
12. Shah NR, Rogers JD, Ewald GA, Pasque MK, Geltman EM, Bailey MS et al. Survival of patients removed from the heart transplant waiting list. J Thorac Cardiovasc Surg 2004;127:1481-5.
13. Kilic A, Conte JV, Shah AS, Yuh DD. Orthotopic heart transplantation in patients with metabolic risk factors. Ann Thorac Surg 2012;93:718-24.
14. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33.
15. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al. Long term mechanical left ventricular assistance for end stage heart failure. N Engl J Med 2001;345:1435-43.
16. Saito S, Westaby S, Piggot D, Katsumataa T, Dudnikova S, Robsona D et al. Reliable long term non-pulsatile circulatory support without anticoagulation. Eur J Cardiothorac Surg 2001;19:678-83.
17. Kuhn M, Vos M, Mitko D, Stypmann J, Schmid C, Kawaguchi N et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end stage heart failure. Cardiovasc Res 2004;64:308-14.
18. Anastasiadis K, Antonitsis P, Argiriadou H, Khayat A, Papakonstantinou C, Westaby S et al. Use of minimal extracorporeal circulation circuit for left ventricular assist device implantation. ASAIO J 2011;57:547-9.
19. Wieselthaler G, Schima H, Czerny M et al.. Decrease of medically unresponsive elevated pulmonary vascular resistance with LVAD. Artif Organs 2001;25:813 (abstract).
20. Xydas S, Rosen RS, Ng C, Mercando M, Cohen J, DiTullio M et al. Mechanical unloading leads to echocardiographic, electrocardiographic neurohormonal and histologic recovery. J Heart Lung Transplant 2006;25: 7-15.
21. Birks EJ, George RS, Hedger M, Bahrami T, Wilton P, Bowles CT et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011;123:381-90.
22. General Medical Council. Treatment and care towards the end of life: good practice in decision making, 2010; http://www.gmc_uk.org.
23. Westaby S, Siegenthaler M, Beyersdorf F, Massetti M, Pepper J, Khayat A et al. Destination therapy with a rotary blood pump and novel power delivery. Eur J Cardiothorac Surg 2010;37: 350-356
24. Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y et al. Clinical outcomes for continuous flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011;30:402-7.
25. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Miller MA et al. Long term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012;144:584-603.
26. Westaby S, Banning A, Neil D, Poole-Wilson P, Frazier OH. Optimism derived from 7.5 years of continuous flow circulatory support. J Thorac Cardiovasc Surg 2012;139:e45-7.
27. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
28. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:535-41.
29. Westaby S. Cardiac transplant or rotary blood pump. Contemporary evidence. J Thorac Cardiovasc Surg 2013;145:24-31.
30. Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol 2009;54:386-96.
31. Lund LH, Mathews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail 2012;12:434-43.
32. Kormos RL, Teuteberg TJ, Pagani FD, Russell SD, John R, Miller LW. Right ventricular failure in patients with HeartMate II continuous flow left ventricular assist device: incidence, risk factors, and effects on outcomes. J Thorac Cardiovasc Surg 2010;139:1316-24.
33. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S et al. Right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010;105:1030-5.
34. Grant ADM, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol 2012;60:521-8.
35. Flint KM, Matlock DD, Lindenfeld J, Allen LA. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail 2012;5:286-93.
36. Acker MA, Pagani FD, Stough WF, Mann D, Jessup M, Kormos R et al. Statement regarding the Pre and Post Market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant 2012;31:1241-52.
37. Krabatsch T, Potapov E, Knosall C, Hetzer R. Ventricular assist devices for all? Eur J Cardiothorac Surg 2012;42:918-9.
38. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ et al. Extended mechanical circulatory support with a continuous flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21.
39. Strueber M, O'Driscoll G, Jansz P, Khagani A, Levy WC, Wieselthaler G. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011;57:1375-82.
40. Adamson RM, Stahovich M, Chillcott S, Baradarian S, Chammas J, Jaski B et al. Clinical strategies and outcomes in advanced heart failure patient older than 70 years of age receiving the HeartMate II left ventricular assist device. J Am Coll Cardiol 2011;57:2487-95.
41. Deng MC, Young JB, Stevenson LW, Oz MC, Rose EA, Hunt SA et al. on behalf of the Board of Directors of the International Society for Heart and Lung Transplantation (ISHLT). Destination mechanical circulatory support- proposal for clinical standards. J Heart Lung Transplant 2003;22:365-9.
42. Jacques LB, Jensen TS, Schafer JH, Baldwin J, Ultrich MM. Decision memo for ventricular assist devices as destination therapy [Internet]. Centers for Medicare and Medicaid Services; 2010: http://www.cms.gov/medicarecoverage-database/details/nca-decisionmemo.aspx?NCAId=243&fromdb=true (8 November 2012, date last accessed).